Article
Microenvironment-Inferred Genotyping: An Exclusionary Classifier for EGFR Amplification When DNA Testing Fails
2025-12-13
Abstract excerpt
EGFR amplification occurs in approximately 40-50% of glioblastoma (GBM) cases and is critical for treatment selection [1]. However, GBM tissue samples frequently yield insufficient material for comprehensive molecular testing due to extensive necrosis and tissue quality limitations [2]. This affects thousands of patients annually in the United States [4]. We developed a microenvironment-inferred genotyping approac...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5928147b-d938-5598-abc6-5ea3406b8ef5
- DOI
- 10.64898/2025.12.10.693431
